Vida Health Valuation, Funding & Investors
Vida Health is valued at $53M as of December 2016.
Last Vida Health valuation
$53M
Series B · Dec 2016
Last Vida Health funding round
$29M
Undisclosed stage · Nov 2023
Cumulative funding Vida Health raised
$217M
across 6 funding rounds
Key investors in Vida Health
Canvas Prime
Aspect Ventures
AME Cloud Ventures
NGP Capital
Ally Bridge Group
Workday Ventures
About Vida Health
Vida Health is a San Francisco-headquartered virtual care platform founded in 2014 that integrates mental and physical health treatment via an AI-driven app. It delivers video sessions, messaging, and content for managing chronic conditions including obesity, diabetes, hypertension, stress, depression, and anxiety. Major U.S. employers and health plans such as HealthPartners partner with Vida to cover millions of lives.
Founded
2014
HQ
San Francisco, CAWebsite
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Valuation
$53M (Dec 2016)
Vida Health Valuation
Vida Health is currently valued at $53M, based on its Series B in December 2016.
The $18M round was led by Canvas Prime, with participation from Aspect Ventures, Khosla Ventures, NGP Capital and The Valley Fund.
Vida Health's valuation has grown 1.3x from $42M at its Series A in October 2014 to $53M in December 2016, across 2 priced rounds.
Vida Health valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Dec 2016 | Series B | $53M |
| Oct 2014 | Series A | $42M |
Vida Health Funding History
Vida Health has raised a total of $217M across 6 funding rounds.
Vida Health's first fundraising round was a $5M Series A in October 2014. The most recent completed round was a $29M undisclosed-stage round in November 2023.
Vida Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Nov 2023 | Undisclosed stage | Ally Bridge Group (lead); Canvas Prime (lead); General Atlantic (lead); Hercules Capital (lead) | $29M | - | Vida Health is a virtual chronic condition care platform offering personalized programs for cardiometabolic conditions such as weight loss, diabetes management, obesity, and mental health support. The app connects users with health coaches who tailor interventions using data from labs, pharmacy claims, devices, biometrics, and member reports. It integrates prescriptive therapies, behavioral support, Cognitive Behavioral Therapy, GLP-1 medications, and Spanish-language interventions, targeting the needs of approximately 40% of U.S. adults affected by cardiometabolic issues. On November 9, 2023, Vida Health closed a $28.5 million financing round led by existing investors Ally Bridge Group (also referred to as Ally Bridge), Canvas Ventures (also Canvas Prime), General Atlantic, and Hercules Capital, with participation from other insiders. The funding supports scaling operations, pursuing growth in the rapidly expanding GLP-1, obesity, and diabetes markets, and enhancing access to affordable treatments. This brings the company's total funding to $216.5 million as of that date. The announcement coincided with a leadership transition: Joe Murad was appointed CEO and board member, succeeding founder Stephanie Tilenius, who moved to an advisory role. Murad brings over 20 years of healthcare and technology experience. Vida emphasized its best-in-class clinical and financial outcomes for enterprise and health plan customers. Post-round, partnerships emerged, such as with Capital Rx to launch Rx Activate on the JUDI platform for broader access to cardiometabolic solutions. |
| May 2021 | Series D | AVP (lead); Centene (lead); General Atlantic (lead); Ardea Partners; GuideWell; AME Cloud Ventures; Aspect Ventures; Workday Ventures; NGP Capital; Canvas Prime; Ally Bridge Group | $110M | - | Vida Health, a San Francisco-based virtual chronic care platform, raised $110 million in its Series D funding round on May 5, 2021, led by General Atlantic with participation from Centene, AXA Venture Partners (AVP), and Ardea Partners. Returning investors included Ally Bridge Group, AME Cloud Ventures, Aspect Ventures, Canvas Ventures (noted as Canvas Prime in query), GuideWell, NGP Capital, and Workday Ventures. The platform integrates cognitive behavioral science to drive long-term behavior changes for conditions like diabetes, hypertension, obesity, depression, stress, and anxiety, offering holistic care for co-occurring physical and mental health issues. Centene's investment followed a successful 20-state deployment of Vida for its Ambetter health insurance marketplace product, yielding positive outcomes in enrollment, member engagement, and health results. The funding aims to scale Vida's provider network, enhance machine learning capabilities, and expand virtual chronic care services after the company tripled its revenue in 2020, though specific revenue figures are not disclosed. General Atlantic highlighted Vida's position at the intersection of virtual care, behavioral health, and healthcare AI analytics. Vida differentiates through its polychronic focus, addressing complex patient needs with a full-spectrum platform. The round supports further market penetration and capability development in a growing digital health sector. |
| Apr 2020 | Undisclosed stage | Ally Bridge Group (lead); AME Cloud Ventures; Aspect Ventures; Workday Ventures; NGP Capital; Canvas Prime; Webb Investment Network | $25M | - | Vida Health is a virtual chronic care platform offering personalized, AI-powered programs for physical and mental health conditions, including coaching from therapists, dietitians, and diabetes educators, with integrations for medical claims, labs, devices, and biometrics to drive behavior change. In April 2020, the company raised $25 million in a venture round led by Ally Bridge Group, with participation from AME Cloud Ventures, Aspect Ventures, Canvas Prime (noted as Canvas Ventures in some sources), NGP Capital, Webb Investment Network, and Workday Ventures, to support growth and enhance service offerings amid rising demand for virtual care. This brought total funding to approximately $83 million at the time. The 2020 round aligned with surging interest in telehealth during the early COVID-19 pandemic, positioning Vida to expand its nationwide provider network. Clients included major employers like Boeing, Visa, Cisco, and eBay, as well as health plans such as Centene, Humana, and Blue Cross Blue Shield. By May 2021, Vida had tripled its revenue since the beginning of 2020 and grown its network by over 400%, launching a full-stack Spanish experience as the first major U.S. virtual chronic care platform to do so. Following the 2020 raise, Vida secured a $110 million Series D in May 2021 led by General Atlantic, with Centene, AXA Venture Partners, and Ardea Partners, plus returning investors including Ally Bridge Group and others, to scale clinician networks, advance machine learning, and broaden commercial efforts. Subsequent rounds included $28.5 million growth equity in November 2023 led by General Atlantic and Ally Bridge Group. Total funding reached over $216 million by 2023. |
| Jun 2019 | Series C | GuideWell; Workday Ventures | $30M | - | Vida Health, a San Francisco-based virtual healthcare company founded in 2014, provides a personalized telemedicine platform combining health coaches, therapists, remote monitoring, and machine learning to manage chronic physical and behavioral conditions such as anxiety, asthma, COPD, diabetes, depression, hypertension, and more. The platform targets enterprise customers including self-funded insurers like eBay, PayPal, and Cisco, as well as health plans managing high-risk populations. On June 19, 2019, Vida Health closed a $30 million Series C funding round with strategic investments from GuideWell Mutual Holding Corporation (associated with Florida Blue), Teladoc Health, and Workday Ventures, alongside participation from existing investors. This brought total funding to approximately $58 million across prior rounds: a $5 million Series A in 2014 (Aspect Ventures, Khosla Ventures, others), an $18 million Series B in 2016 (Canvas Ventures lead, Nokia Growth Partners, Aspect Ventures, Khosla Ventures), and the Series C. The new capital supports expansion of sales and marketing to scale market presence, particularly for mental health and chronic disease management. Partnerships include GuideWell integrating Vida's services for members with comorbidities to improve outcomes and cost savings, and Workday Ventures enabling single sign-on integration for joint customers. Recent product updates featured an enterprise platform with targeted solutions and Habit Bundles addressing lifestyle factors like sleep, nutrition, and stress. |
| Dec 2016 | Series B | Canvas Prime (lead); Aspect Ventures; Khosla Ventures; NGP Capital; The Valley Fund | $18M | $53M | Vida Health, founded in 2014, develops a digital health platform pairing individuals with expert health coaches for managing chronic conditions and improving health. The platform integrates personalized care programs, connects to over 100 apps and devices, and pulls data from sources like labs and claims for tailored experiences. By December 2016, Vida had coached tens of thousands of individuals, processed over 4 million messages and 7 million data points, and partnered with Fortune 500 employers like Steelcase, eBay, and FICO, insurer UnitedHealthcare, and medical centers including Duke Medicine and Stanford Medicine. In December 2016, Vida Health raised approximately $18 million across Series B-1, B-2, and B-3 rounds totaling $17.41 million + $100,163.57 + $320,855.97 at a post-money valuation of $52.86 million. The rounds included investors Aspect Ventures, Canvas Ventures (lead), Khosla Ventures, and Nokia Growth Partners. Funds supported expansion of the digital health coaching platform to serve more consumers managing chronic conditions. Vida's approach combines mobile coaching, evidence-based clinical programs, and device monitoring, shown to benefit patients with chronic diseases by providing ongoing support between doctor visits, as evidenced in a clinical trial with MD Anderson Cancer Center for cancer patients. |
| Oct 2014 | Series A | Signia Venture Partners; Lorrie Norrington; AME Cloud Ventures; George Battle; Aspect Ventures; Khosla Ventures; The Valley Fund; Maynard Webb; StartX (Stanford-StartX Fund); Oxeon Partners; Kevin Scott | $5M | $42M | Vida Health raised $5.04 million in its Series A round and $3.7 million in Series A-1 on October 28, 2014, from investors including Aspect Ventures, Jerry Yang, Kevin Scott, Khosla Ventures, Maynard Webb, Signia Venture Partners, Skip Battle, and The Valley Fund, achieving a post-money valuation of $41.57 million. The San Francisco-based company operates a digital health platform that pairs users with health coaches for managing chronic conditions such as diabetes, hypertension, anxiety, and depression, as well as wellness coaching. The funding established a foundation for initial product development and served over 30,000 individuals by 2016. |
Who has invested in Vida Health?
22 investors have backed Vida Health across its funding rounds, including Canvas Prime, Aspect Ventures, AME Cloud Ventures, NGP Capital, Ally Bridge Group and Workday Ventures.
Lead investors include Ally Bridge Group, Canvas Prime, General Atlantic, Hercules Capital, AVP and 1 other investor.
Vida Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| San Francisco, CA | 4 | Participant | Oct 2014 | |
| San Francisco, CA | 4 | Lead | Dec 2016 | |
| San Francisco, CA | 3 | Participant | Oct 2014 | |
| San Francisco, CA | 3 | Participant | Jun 2019 | |
| San Francisco, CA | 3 | Participant | Dec 2016 | |
 Hong Kong | 3 | Lead | Apr 2020 | |
| Jacksonville, FL | 2 | Participant | Jun 2019 | |
| San Francisco, CA | 2 | Participant | Oct 2014 | |
| New York City, NY | 2 | Lead | May 2021 | |
| San Francisco, CA | 2 | Participant | Oct 2014 | |
| New York City, NY | 1 | Participant | May 2021 | |
| San Francisco, CA | 1 | Participant | Oct 2014 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Lorrie Norrington | San Francisco, CA | 1 | Participant | Oct 2014 |
This data is available for Pro users. Sign up to see all 22 Vida Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialVida Health Competitors
Vida Health competitors include listed companies like EUDA Health and Rocket Doctor AI, and private ones like Health Recovery Solutions, Mindset Health, Docly International AB and Seniorlink.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Hoboken, NJ | Private | - | - | $37M | - | |
 Singapore | Publicly listed | $7M | ($2M) | $52M | 5.9x | |
 Melbourne | Private | - | - | $52M | - | |
 Malmö | Private | - | - | $52M | - | |
| Boston, MA | Private | - | - | $55M | - | |
 Canada | Publicly listed | $1M | ($10M) | $43M | 20.7x |
Vida Health Public Comps
Vida Health is still privately-owned, but its public comps include Health In Tech, EUDA Health, Data Horizon, MeVis, SMAIO, SOFTMAX, Susmed, Nano X Imaging, Rocket Doctor AI and TelyRx.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $33M | $2M | 1.4x | 1.2x | 21.6x | (17.6x) | |||
| $7M | ($2M) | 8.0x | 5.9x | (26.0x) | - | |||
| $33M | $4M | 2.1x | - | 15.7x | - | |||
| $18M | $4M | 2.4x | - | 11.6x | - | |||
| $11M | ($1M) | 4.4x | 3.8x | (41.5x) | (39.3x) | |||
| $45M | $5M | 1.0x | 1.0x | 8.3x | - | |||
| $3M | ($2M) | 7.4x | 5.6x | (11.8x) | - | |||
| $13M | ($67M) | 2.9x | 2.1x | (0.6x) | - | |||
This data is available for Pro users. Sign up to see all Vida Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Vida Health
| When was Vida Health founded? | Vida Health was founded in 2014. |
| Where is Vida Health headquartered? | Vida Health is headquartered in San Francisco, CA, United States. |
| Is Vida Health publicly listed? | No, Vida Health is a private, VC-backed company. |
| What is Vida Health's valuation? | Vida Health was last valued at $53M in its Series B in December 2016. |
| How much funding has Vida Health raised? | Vida Health has raised $217M across 6 funding rounds. |
| What was Vida Health's last funding round? | Vida Health's last funding round was a $29M undisclosed-stage round in November 2023, led by Ally Bridge Group, Canvas Prime, General Atlantic and Hercules Capital. |
| Who are Vida Health's investors? | Vida Health's investors include Aspect Ventures, Canvas Prime, AME Cloud Ventures, Workday Ventures, NGP Capital, Ally Bridge Group, GuideWell, Khosla Ventures, General Atlantic, The Valley Fund and 12 others. |
| Which companies are comparable to Vida Health? | Companies comparable to Vida Health include Health Recovery Solutions, EUDA Health, Mindset Health, Docly International AB, Seniorlink and Rocket Doctor AI. |
See companies similar to Vida Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.